Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rabbit Anti-Equine IgG Polyclonal Antibody-[FITC]

Product Overview

BioVenic rabbit polyclonal antibody is specific for equine IgG. It is affinity purified by CA-AS. It can be applied to ELISA assay of equine IgG.

Specifications

Application ELISA

Clonality Polyclonal

Classification Primary Antibody

Clone J1N67

Host Rabbit

Target Species Equine

Species Reactivity Equine

Specificity Equine IgG

Isotype IgG

Immunogen Recombinant protein of IgG

Purification Purified by CA-AS

Conjugation FITC

Buffer 0.01M Phosphate Buffered Saline, pH 7.4

Physical State Liquid

Target Information

Equine IgG is a crucial component of the immune system in horses, with seven subclasses identified, each with distinct effector functions that have implications for vaccine strategies. These subclasses vary in their ability to interact with Fc receptors on effector cells and activate the complement system via the classical pathway. IgG1, IgG3, IgG4, and IgG7 are particularly effective in eliciting a strong respiratory burst from equine peripheral blood leukocytes and in binding complement C2q.

Target Equine IgG

Shipping and Storage

This product is shipped with wet ice packs. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Lewis, Melanie J., et al. "The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies." Molecular immunology 45.3 (2008): 818-827.